Skip Over Navigation LinksHome  |  Site Map  |  Contact Us   
  Search Tips 
Biomedical Technology Clinical Research Comparative Medicine Research Infrastructure
Go to the National Institutes of Health Web site  
Research Funding Opportunities
Access to Scientific Resources
About NCRR
News and Events
Publications, Plans, and Reports
Spacer GIF Spacer GIF Spacer GIF
Back to > Previous Page
 
Clinical Research Resources Directory

National Gene Vector Laboratories

 
Coordinating Center for the National Gene Vector
Laboratories
Department of Medical and Molecular Genetics
Medical Science Building, University of Indiana
635 Barnhill Drive, MS 205
Indianapolis, IN 46202-5121

Grant No. U42 RR11148
For information about these resources and how to access them, please contact:

Project Coordinator
Lorraine Matheson
317-274-4519; Fax: 317-274-4518
E-mail: lrubin@iupui.edu

Background

The National Gene Vector Laboratories (NGVLs) help researchers obtain adequate quantities of clinical-grade vectors for human gene transfer protocols. The NGVLs consist of three vector production centers at Baylor College of Medicine; City of Hope National Medical Center and Beckman Research Institute; and Indiana University, which also is the Coordinating Center for the activities of all the laboratories. In addition, two other laboratories conduct toxicology studies for investigators upon approval by the NGVL steering committee. These centers are located at the Southern Research Institute and the University of Florida.

Application for Services

Application packages are available from the Project Coordinator listed above. Completed applications should be received at the Coordinating Center by March 1 or September 15. However, an expedited review process is available to investigators who have both obtained provisional IRB approval and registered with the NIH Office of Biotechnology Activities. Such requests can be submitted at any time.

Review of Applications

The NGVL Scientific Review Board will evaluate applications for preclinical data; understanding of the molecular mechanism of the targeted disease; protocol design; qualifications of the investigator and the laboratory and clinical facilities; ethical implications of the proposed research; plans to protect human subjects; and compliance with regulatory, minority and gender guidelines. The NGVL Prioritization Committee will evaluate completed reviews, assign priority scores, and rank applications. Its recommendations are then conveyed to the NGVL Steering Committee for final disposition.

Key Staff Members

Program Director and Principal Investigator
Kenneth Cornetta, M.D.
317-274-2240; Fax: 317-274-2387
E-mail: kcornetta@iupui.edu

Production Laboratory Manager
Christopher Ballas, Ph.D.
317-278-1628; Fax: 317-278-3327
e-mail: cballas@iupui.edu

Center Resources

Special Services, Facilities, or Instruments

  • Coordinating center houses the public toxicology databases.
  • Facilities are compliant with Good Manufacturing Practice (GMP)/Good Laboratory Practice (GLP) guidelines for the production of retrovirus, adenovirus, adeno-associated virus, herpes virus, lentivirus, and DNA plasmid vectors for use in Phase I and II clinical gene therapy trials.
  • GLP laboratories provide safety testing and certification.
  • GMP/GLP laboratories and animal facilities provide toxicology services
Back to Top

 

[Biomedical Technology | Clinical Research | Comparative Medicine | Research Infrastructure]
[Home | Accessibility Compliance | Contact Us | Disclaimer | FOIA | Privacy | Site Map]
National Center for Research Resources (NCRR)
National Institutes of Health
One Democracy Plaza, 9th Floor
6701 Democracy Boulevard, MSC 4874
Bethesda, MD 20892-4874
NIH Logo National Institutes of Health (NIH)
Bethesda, Maryland 20892
DHHS Logo Department of Health
and Human Services
Go to FirstGov Web Site